ICU Medical, Inc. (NASDAQ:ICUI ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants John Mills – ICR, IR Vivek Jain – Chief Executive Officer and Chairman Brian Bonnell – Chief Financial Officer Conference Call Participants Jayson Bedford – Raymond James Brett Fishbin – KeyBanc Capital Markets Larry Solow – CJS Securities Michael Toomey – Jefferies Operator Good day, a...
BOSTON, MA / ACCESS Newswire / May 8, 2025 / Block & Leviton is investigating ICU Medical, Inc. (Nasdaq:ICUI) for potential securities law violations. Investors who have lost money in their ICU Medical, Inc. investment should contact the firm to learn more about how they might recover those losses.
SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2025.
The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. SAN CLEMENTE, Calif.
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ICU Medical, Inc. (Nasdaq: ICUI) for potential securities law violations. Investors who have lost money in their ICU Medical, Inc. investment should contact the firm to learn more about how they might recover those losses.
SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2025 earnings release and conference call.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ICU MEDICAL, INC. (ICUI), CL...
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ICU MEDICAL, INC. (ICUI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLA...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.